10-122834960-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_022034.6(CUZD1):āc.1128A>Gā(p.Ile376Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_022034.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUZD1 | NM_022034.6 | c.1128A>G | p.Ile376Met | missense_variant | 7/9 | ENST00000392790.6 | NP_071317.2 | |
CUZD1 | NR_037912.2 | n.991A>G | non_coding_transcript_exon_variant | 6/8 | ||||
FAM24B-CUZD1 | NR_037915.1 | n.1804A>G | non_coding_transcript_exon_variant | 9/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUZD1 | ENST00000392790.6 | c.1128A>G | p.Ile376Met | missense_variant | 7/9 | 1 | NM_022034.6 | ENSP00000376540.1 | ||
ENSG00000286088 | ENST00000368904.6 | n.*289A>G | non_coding_transcript_exon_variant | 8/10 | 1 | ENSP00000357900.2 | ||||
ENSG00000286088 | ENST00000368904.6 | n.*289A>G | 3_prime_UTR_variant | 8/10 | 1 | ENSP00000357900.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461566Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727088
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at